xanthine has been researched along with mycophenolic acid in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (21.05) | 18.7374 |
| 1990's | 3 (15.79) | 18.2507 |
| 2000's | 6 (31.58) | 29.6817 |
| 2010's | 6 (31.58) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Auschwitz, JM; Dubey, JP; Ferreira, LR; Fomovska, A; Hickman, MR; Lee, PJ; Leed, SE; McLeod, R; Mui, E; Roberts, C; Sommerville, C; Welsh, WJ; Wood, RD; Woods, S | 1 |
| Alexiou, M; Leese, HJ | 1 |
| Cheung, KS; Hedstrom, L; Wang, CC | 1 |
| Hedstrom, L; Wang, CC | 1 |
| Fung, E; Hodges, SD; Lin, CC; Snyder, FF | 1 |
| Chaney, SG; Hall, IH; Holbrook, DJ; Lee, KH; Page, JD | 1 |
| Hoshi, M; Mizuno, A; Yuki, A | 1 |
| Farley, BA; Ohlsson-Wilhelm, BM; Rowley, PT; Rudolph, NS | 1 |
| Bauer, S; Braun, KP; Budde, K; Fritsche, L; Glander, P; Hambach, P; Mai, I; Neumayer, HH; Roots, I; Waiser, J | 1 |
| Luecke, H; Prosise, GL | 1 |
| Guillén Schlippe, YV; Hedstrom, L; Riera, TV; Seyedsayamdost, MR | 1 |
| Athias, P; Bès, S; Rochette, L; Tatou, E; Tissier, C; Vandroux, D | 1 |
| Berg, A; Boitz, JM; Dobie, F; Jardim, A | 1 |
| Chakraborty, U; Foley, JP; Zhang, J | 1 |
| Maiguma, T; Oishi, R; Okabe, Y; Otsubo, K; Sugitani, A; Tanaka, M; Teshima, D; Yosida, T | 1 |
| Hansen, BG; Hedstrom, L; Sun, XE | 1 |
| Anderson, WF; Binkowski, TA; Gollapalli, DR; Gornicki, P; Hedstrom, L; Jedrzejczak, R; Joachimiak, A; Kim, Y; Kuhn, ML; Mack, JC; Makowska-Grzyska, M; Maltseva, N; Mulligan, R; Wang, XK; Wilton, R; Wu, R; Zhang, R | 1 |
| Bemer, MJ; Boeckh, MJ; Duan, H; McCune, JS; Phillips, BR; Raccor, BS; Risler, LJ; Sandmaier, BM; Storer, BE; Wang, J | 1 |
| Kawakami, J; Mino, Y; Naito, T; Ogawa, N; Shimoyama, K | 1 |
1 trial(s) available for xanthine and mycophenolic acid
| Article | Year |
|---|---|
Recipient pretransplant inosine monophosphate dehydrogenase activity in nonmyeloablative hematopoietic cell transplantation.
Topics: Acute Disease; Adult; Aged; Biomarkers; Female; Graft Survival; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; IMP Dehydrogenase; Inosine Monophosphate; Leukocytes, Mononuclear; Male; Middle Aged; Mycophenolic Acid; Prognosis; Prospective Studies; Recurrence; Ribonucleotides; Survival Analysis; Transplantation Chimera; Transplantation, Homologous; Xanthine | 2014 |
18 other study(ies) available for xanthine and mycophenolic acid
| Article | Year |
|---|---|
Salicylanilide inhibitors of Toxoplasma gondii.
Topics: Animals; Antimalarials; Antiparasitic Agents; Cells, Cultured; Drug Resistance; Female; Fibroblasts; Humans; Mice; Mice, Transgenic; Plasmodium falciparum; Salicylanilides; Structure-Activity Relationship; Toxoplasma; Toxoplasmosis | 2012 |
Purine utilisation, de novo synthesis and degradation in mouse preimplantation embryos.
Topics: Adenine; Animals; Azaserine; Blastocyst; Cells, Cultured; Chromatography, High Pressure Liquid; Guanine; Hypoxanthines; Mice; Mice, Inbred Strains; Mycophenolic Acid; Purines; Xanthine; Xanthines | 1992 |
A novel mechanism of mycophenolic acid resistance in the protozoan parasite Tritrichomonas foetus.
Topics: Adenine; Animals; Cloning, Molecular; Drug Resistance; Guanine; Guanine Nucleotides; Hypoxanthine; Hypoxanthine Phosphoribosyltransferase; Hypoxanthines; IMP Dehydrogenase; Ketone Oxidoreductases; Mutation; Mycophenolic Acid; Tritrichomonas; Xanthine; Xanthines | 1990 |
Mycophenolic acid and thiazole adenine dinucleotide inhibition of Tritrichomonas foetus inosine 5'-monophosphate dehydrogenase: implications on enzyme mechanism.
Topics: Adenine Nucleotides; Animals; Binding Sites; Binding, Competitive; IMP Dehydrogenase; Isomerism; Ketone Oxidoreductases; Kinetics; Mycophenolic Acid; NAD; Ribonucleotides; Tritrichomonas; Xanthine | 1990 |
Increased inosinate dehydrogenase activity in mycophenolic acid resistant neuroblastoma cells.
Topics: Animals; Cell Line; Drug Resistance; IMP Dehydrogenase; Ketone Oxidoreductases; Mice; Mycophenolic Acid; Neuroblastoma; Ribonucleotides; Time Factors; Xanthine | 1986 |
Inhibition of inosine monophosphate dehydrogenase by sesquiterpene lactones.
Topics: Animals; Glutathione; Humans; IMP Dehydrogenase; Ketone Oxidoreductases; Kinetics; Lactones; Leukemia P388; Mycophenolic Acid; Ribonucleotides; Sesquiterpenes; Tumor Cells, Cultured; Xanthine | 1987 |
Restoration by xanthine of development of mouse embryos inhibited by mycophenolic acid.
Topics: Animals; Blastocyst; Cells, Cultured; Embryo Transfer; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Mycophenolic Acid; Xanthine; Xanthines | 1988 |
Erythroid induction of K562 human leukemia cells: enhancement by purines.
Topics: Adenine; Cell Cycle; Cell Division; Cell Line; Drug Synergism; Guanine; Hemoglobins; Humans; Hypoxanthine; Hypoxanthines; Leukemia; Mycophenolic Acid; Thymidine; Xanthine; Xanthines | 1985 |
Non-radioactive determination of inosine 5'-monophosphate dehydro-genase (IMPDH) in peripheral mononuclear cells.
Topics: Adult; Chromatography, High Pressure Liquid; Enzyme Inhibitors; Female; Humans; IMP Dehydrogenase; Leukocytes, Mononuclear; Male; Middle Aged; Mycophenolic Acid; Reproducibility of Results; Ribonucleotides; Xanthine | 2001 |
Crystal structures of Tritrichomonasfoetus inosine monophosphate dehydrogenase in complex with substrate, cofactor and analogs: a structural basis for the random-in ordered-out kinetic mechanism.
Topics: Animals; Binding Sites; Catalysis; Crystallization; Crystallography, X-Ray; Enzyme Inhibitors; Humans; IMP Dehydrogenase; Inosine Monophosphate; Kinetics; Models, Molecular; Mycophenolic Acid; NAD; Protein Conformation; Ribavirin; Ribonucleotides; Tritrichomonas foetus; Xanthine | 2003 |
Substitution of the conserved Arg-Tyr dyad selectively disrupts the hydrolysis phase of the IMP dehydrogenase reaction.
Topics: Adenosine Diphosphate; Alanine; Amino Acid Substitution; Animals; Arginine; Binding Sites; Cattle; Conserved Sequence; Deuterium Exchange Measurement; Enzyme Inhibitors; Hydrolysis; IMP Dehydrogenase; Kinetics; Mutagenesis, Site-Directed; Mycophenolic Acid; Phenylalanine; Point Mutation; Protein Binding; Ribavirin; Ribonucleosides; Ribonucleotides; Solvents; Substrate Specificity; Tritrichomonas foetus; Tyrosine; Xanthine | 2004 |
Physiological and metabolic actions of mycophenolate mofetil on cultured newborn rat cardiomyocytes in normoxia and in simulated ischemia.
Topics: Adenosine; Animals; Animals, Newborn; Cell Hypoxia; Cells, Cultured; Hypoxanthine; Immunosuppressive Agents; Membrane Potentials; Mycophenolic Acid; Myocardial Ischemia; Myocardial Reperfusion; Myocytes, Cardiac; Rats; Rats, Wistar; Xanthine | 2004 |
Kinetic characterization of inosine monophosphate dehydrogenase of Leishmania donovani.
Topics: Amino Acid Sequence; Animals; Enzyme Inhibitors; Escherichia coli; Guanosine Monophosphate; Inosine Monophosphate; Leishmania donovani; Microbodies; Microscopy, Confocal; Mycophenolic Acid; NAD; Peroxisome-Targeting Signal 1 Receptor; Phylogeny; Protein Binding; Protozoan Proteins; Receptors, Cytoplasmic and Nuclear; Recombinant Proteins; Ribonucleotides; Sequence Alignment; Subcellular Fractions; Substrate Specificity; Xanthine | 2007 |
Determination of residual cell culture media components by MEKC.
Topics: Chromatography, Micellar Electrokinetic Capillary; Culture Media; Folic Acid; Hydrogen-Ion Concentration; Hypoxanthine; Limit of Detection; Mycophenolic Acid; Niacin; Reproducibility of Results; Riboflavin; Sensitivity and Specificity; Sodium Dodecyl Sulfate; Xanthine | 2009 |
Evaluation of inosin-5'-monophosphate dehydrogenase activity during maintenance therapy with tacrolimus.
Topics: Adult; Biomarkers, Pharmacological; Chromatography, High Pressure Liquid; Drug Interactions; Drug Monitoring; Drug Therapy, Combination; Enzyme Inhibitors; Female; Humans; Immunosuppressive Agents; IMP Dehydrogenase; Kidney Transplantation; Kinetics; Leukocytes, Mononuclear; Male; Middle Aged; Mycophenolic Acid; Prodrugs; Reproducibility of Results; Ribonucleotides; Tacrolimus; Xanthine; Young Adult | 2010 |
Kinetically controlled drug resistance: how Penicillium brevicompactum survives mycophenolic acid.
Topics: Animals; Cricetinae; Drug Resistance, Fungal; Enzyme Inhibitors; IMP Dehydrogenase; Kinetics; Models, Molecular; Mycophenolic Acid; Penicillium; Protein Conformation; Ribonucleotides; Xanthine | 2011 |
Bacillus anthracis inosine 5'-monophosphate dehydrogenase in action: the first bacterial series of structures of phosphate ion-, substrate-, and product-bound complexes.
Topics: Amino Acid Sequence; Apoenzymes; Bacillus anthracis; Benzimidazoles; Catalytic Domain; Enzyme Inhibitors; IMP Dehydrogenase; Inosine Monophosphate; Models, Molecular; Molecular Sequence Data; Mycophenolic Acid; NAD; Protein Binding; Ribonucleotides; Triazoles; Xanthine | 2012 |
Mycophenolic acid exposure and complement fraction C3 influence inosine 5'-monophosphate dehydrogenase activity in systemic lupus erythematosus.
Topics: Adult; Body Weight; Complement C3; Cross-Sectional Studies; Drug Administration Schedule; Female; Glucuronides; Humans; Immunosuppressive Agents; IMP Dehydrogenase; Lupus Erythematosus, Systemic; Male; Middle Aged; Multivariate Analysis; Mycophenolic Acid; Remission Induction; Ribonucleotides; Xanthine | 2017 |